Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Registry on Luma Vision's VERAFEYE System (ENLIgHT)

View source ↗

Summary

Clinical trial registry entry for LUMA Vision's VERAFEYE ENLIgHT system studying atrial fibrillation and atrial arrhythmias; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: LUMA Vision Ltd. | Conditions: Atrial Fibrillation, Left Atrial Appendage Closure | Status: NOT_YET_RECRUITING